Please login to the form below
UTI
This page shows the latest UTI news and features for those working in and with pharma, biotech and healthcare.
NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
This process can take up to 72 hours, with NICE reporting that a suspected UTI is often initially treated with broad spectrum antibiotics before the lab results are back.
Latest news
-
Locus Biosciences announces first patient treated in urinary tract infection trial
Around 80% of UTI cases are caused by E coli, often including strains that are antibiotic resistant.
-
FDA green lights study of phage-based drug for resistant infections
strain. Arms of the study will also focus on specific bacteria, namely Escherichia coli and Klebsiella pneumoniae which are common UTI pathogens and prone to MDR. ... The main objective is to identify ideal bacteriophage regimens based on disease control
-
GSK takes new-class antibiotic into phase 3 for serious infections
EAGLE-1 will compare gepotidacin – a triazaacenaphthylene bacterial topoisomerase inhibitor developed in collaboration with US federal agencies – to the azithromycin/ceftriaxone regimen, while EAGLE-2 will use standard UTI therapy
-
Report calls for backing for synthetic biology
Biosensors are currently being developed that can detect urinary tract infections (UTI). ... When they come into contact with a UTI, a response is triggered in one of the constituent proteins, which fluoresces.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Why diagnostics investments are crucial to win the AMR battle
It has developed a rapid urinary tract infection (UTI) test based on single cell microscopy in a nanofluidic chip. ... The test detects the presence of bacteria-causing UTIs within 15 minutes and can identify the appropriate antibiotic to treat 90% of UTI
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Amgen reports positive results for Otezla in psoriatic arthritis
- Supply chain challenges in 2023
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
